Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia

Published:2020-04-23 Issue:7 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Truong Tony H¹^ORCID,Pole Jason D²,Bittencourt Henrique³,Schechter Tal⁴,Cuvelier Geoff D. E.⁵,Paulson Kristjan⁵,Rayar Meera⁶,Mitchell David⁷,Schultz Kirk R.⁶,O'Shea Debbie¹,Barber Randy⁸,Sung Lillian⁴

Affiliation:

1. Division of Pediatric Oncology Blood and Marrow Transplant Alberta Children's Hospital Calgary Alberta Canada

2. The University of Queensland, Centre for Health Services Research Brisbane Australia

3. Division of Hematology/Oncology St. Justine University Hospital Center Montreal Quebec Canada

4. Division of Hematology/Oncology Hospital for Sick Children Toronto Ontario Canada

5. Manitoba Blood and Marrow Transplant Program Cancer Care Manitoba Winnipeg Manitoba Canada

6. Division of Hematology/Oncology British Columbia Children's Hospital Vancouver British Columbia Canada

7. Division of Hematology/Oncology Montreal Children's Hospital Montreal Quebec Canada

8. C17 Research Network C17 Council Edmonton Alberta Canada

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28263

Reference30 articles.

1. Hematopoietic Stem Cell TransplantationA Global Perspective

2. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors.

3. Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study

4. Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey

5. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid Leukemia;Current Oncology;2022-07-22